| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.088 | 0.003 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |